Instant Access with secure payment processing: $195 / One Month $750 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Patent Expiration - 2022

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Type Patent Number Patent Expiration Patented / Exclusive Use Astrazeneca ZOLADEX goserelin acetate 019726 Dec 29, 1989 RX 7,118,552 Apr 13, 2022 Astrazeneca ZOLADEX goserelin acetate 020578 Jan 11, 1996 RX 7,118,552 Apr 13, 2022 Daiichi Sankyo WELCHOL colesevelam hydrochloride 021176 May 26, 2000 RX 7,229,613 Apr 17, 2022 TREATMENT OF TYPE 2 DIABETES MELLITUS Allergan COMBIGAN brimonidine tartrate; timolol maleate 021398 Oct 30, 2007 RX 7,030,149 Apr 19, 2022 REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE TWICE DAILY Allergan COMBIGAN brimonidine tartrate; timolol maleate 021398 Oct 30, 2007 RX 7,320,976 Apr 19, 2022 REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE TWICE DAILY

 Complete access available with subscription